Premium
A PHASE 1 STUDY OF THE ANTI‐CD37 ANTIBODY‐DRUG CONJUGATE AGS67E IN ADVANCED LYMPHOID MALIGNANCIES. INTERIM RESULTS
Author(s) -
Sawas A.,
Savage K.J.,
Perez R.P.,
Advani R.H.,
Zaine J.M.,
Lackey J.M.,
Trave F.,
Anand B.,
Chu R.,
Reyno L.M.,
O'Connor O.A.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_32
Subject(s) - medicine , antibody drug conjugate , chronic lymphocytic leukemia , mycosis fungoides , lymphoma , mantle cell lymphoma , follicular lymphoma , radioimmunotherapy , antibody , oncology , cancer research , leukemia , immunology , monoclonal antibody